CSPIA
BLUE

Cary Street Partners Investment Advisory’s bluebird bio BLUE Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80
Closed -$4.88K – 767
2023
Q3 		$4.88K Hold
80
– – ﹤0.01% 1489
2023
Q2 		$5.28K Buy
80
+75
+1,500% +$5.49K ﹤0.01% 1401
2023
Q1 		$334 Hold
5
– – ﹤0.01% 1627
2022
Q4 		$727 Buy
+5
New +$704 ﹤0.01% 1599

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Cary Street Partners Investment Advisory's BLUE Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 80 shares — an estimated $4.88K sold.

Cary Street Partners Investment Advisory first reported a position in BLUE in Q4 2022 and held it in 4 quarters. The position peaked at $5.28K in Q2 2023. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 80 bluebird bio shares in Q4 2023, an estimated $4.88K.
  • Cary Street Partners Investment Advisory first reported a position in bluebird bio in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's bluebird bio position peaked at $5.28K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.